Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate


NuvaRing Manufacturer & FDA Warnings

warnings for nuvaringDue to the marketing efforts of Merck, which touted NuvaRing as a safe and convenient alternative to birth control pills, the vaginal ring contraceptives have been used by millions of women since they were released in 2001.

Recently, however, the FDA and several drug safety experts have issued NuvaRing warnings, cautioning patients that the devices may increase the risk of blood clots, DVT, stroke and pulmonary embolism.

Although vaginal ring contraceptives may contain lower doses of hormones, the chemicals are released directly and constantly into the bloodstream. This can result in many women receiving a higher overall dose than with traditional pills, increasing potassium levels in the blood and the risk for blood clots.

Due to the failure of Merck to give patients adequate NuvaRing warnings of these risks, they now face more than 1,000 lawsuits in a federal multi-district litigation court. A judge recently scheduled trials to begin in early 2013, however, lawyers are still helping those affected who have not filed claims.

If you or a loved one suffered a blood clot, pulmonary embolism, DVT or stroke after using NuvaRing, it is important to learn about your legal options. Contact us today to speak with a lawyer.

Since NuvaRing was released, the FDA has received more than 1,000 reports of blood clot injuries among women using the device.


FDA Study Shows Increased Risk of Blood Clots

The first NuvaRing warnings came in October of 2011, when the FDA published a study showing vaginal ring contraceptives could raise the risk of blood clots, DVT and pulmonary embolism by up to 56% over traditional low-dose estrogen birth control pills.

The British Medical Journal followed in May of 2012, releasing a study from Denmark which found vaginal rings similar to NuvaRing could increase the risk of blood clots by as much as 90% over oral contraceptives.

The latest NuvaRing warnings came on June 14, 2012, when the New England Journal of Medicine published research linking vaginal ring contraceptives to a 2.5 to 3-fold increased risk of blood clots.

As litigation over NuvaRing injuries continues, the judge overseeing these cases recently ordered that Merck will have to disclose safety tests which were previously hidden from the public. Experts believe these unsealed documents may show Merck knew of blood clot risks from their devices for years, but didn’t warn patients.

Lawyers around the country continue to help those women injured after using NuvaRing file claims. They are available to discuss your case today, as well as how long you have to take action.

Lawsuits such as this for drug and device injuries can be complex and highly specialized. Before you choose a lawyer, make sure they are qualified for this type of lawsuit and have experience fighting large drug companies. The DrugRisk Resource Center only recommends law firms that specialize in NuvaRing lawsuits.

Contact us today for more information on the side effects, research and litigation related to NuvaRing, or to speak with a lawyer. We are available 24 hours a day to provide help.